Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Human Genetics

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...

Factors Affecting Drug Response: Overview

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...

Pharmacogenetics of Drug Metabolism: Overview

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Real-world effectiveness and safety of intranasal esketamine for treatment-resistant depression: data from the enTRD registry.

European psychiatry : the journal of the Association of European Psychiatrists·2026

Same author

From clicks to curiosity: Exploring self-directed information seeking as a behavioral manifestation of curiosity.

Journal of experimental psychology. Applied·2026

Same author

[Digital health applications for depressive disorders in Germany : A narrative review of the evidence and integration into treatment].

Der Nervenarzt·2025

Same author

Effectiveness of Omega-3 Fatty Acids Versus Placebo in Subjects at Ultra-High Risk for Psychosis: The PURPOSE Randomized Clinical Trial.

Schizophrenia bulletin·2024

Same author

Task-irrelevant decorative pictures increase cognitive load during text processing but have no effects on learning or working memory performance: an EEG and eye-tracking study.

Psychological research·2024

Same author

Tetrahydrocannabinol in Pediatrics: Room for Improvement?

Medical cannabis and cannabinoids·2023

Search research articles

Related Experiment Video

Updated: May 27, 2026

The Forced Swim Test as a Model of Depressive-like Behavior

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

Imaging genetics: implications for research on variable antidepressant drug response.

Ulrich Rabl¹, Christian Scharinger, Markus Müller

¹>Division of Biological Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

Expert Review of Clinical Pharmacology

|November 25, 2011

Summary

Genetic variations influence depression and antidepressant response. Integrating imaging genetics with pharmacogenetics may improve understanding of treatment outcomes and brain mechanisms.

More Related Videos

The Mouse Forced Swim Test

The Mouse Forced Swim Test

Published on: January 29, 2012

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Related Experiment Videos

Last Updated: May 27, 2026

The Forced Swim Test as a Model of Depressive-like Behavior

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

The Mouse Forced Swim Test

The Mouse Forced Swim Test

Published on: January 29, 2012

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Area of Science:

Neuroscience
Pharmacogenetics
Psychiatry

Background:

Genetic variations in SLC6A4, HTR1A, MAOA, COMT, and BDNF are linked to depression and varied antidepressant responses.
Antidepressants modulate brain regions involved in emotion processing, areas influenced by these genetic factors.

Purpose of the Study:

To provide a comprehensive overview of pharmacogenetic, imaging genetics, and drug response studies.
To explore how imaging techniques can enhance the understanding of antidepressive drug therapy and individual responses.

Main Methods:

Review of existing pharmacogenetic studies utilizing psychometric measures.
Analysis of imaging genetics studies investigating brain function and structure.
Integration of findings from both pharmacogenetic and neuroimaging research.

Main Results:

Pharmacogenetic studies are often limited by small effect sizes in predicting drug response.
Intermediate endophenotypes, suggested by imaging studies, may help overcome limitations in current pharmacogenetic research.
Imaging genetics offers a pathway to strengthen the link between genes and drug response.

Conclusions:

Integrating neuroimaging with pharmacogenetics can provide deeper insights into the neurobiology of depression.
This combined approach holds promise for understanding individual variability in antidepressant drug response.
Future research should focus on utilizing imaging techniques to refine our understanding of gene-drug interactions in depression treatment.